Curexo Inc. · KRX:060280
Curexo — Non-Deal Roadshow (June 2025)
21 slides from Curexo's roadshow presentation, Jun 19, 2025
Slide 1: CUREXO Investor Relations
gl CUREXO roworics vevowe cane
Slide 2: Disclaimer
gl CUREXO roworics vevowe cane Disclaimer SARE (sl) SARSS HO AAS|E Presentationol|M2| JUSS SAOe AAS AAA (OlS| Barolo ase ict = Aj20| Bete “OSS e SHS HO! ApS 7142/2 HS SSSAUC Ol B77t OF O]AHo| Ape | EASORE ‘Ola! A a A 718 ‘JICH (E) Saree S013 Beyetch. 91 “oJ” < a8 2 Seto] Hs} So ef SYSUO, VAY? BSA SU
Slide 3: A Medical Robot Company offering differentiated healthcare solutions
A Medical Robot Company that offers differentiated healthcare solutions based on advanced technology.
Slide 4: Company overview
회사명 큐렉소 주식회사 설립일 1992.02.29 상장일 2002.07.03 30.9% 1.7% 67.4% 대표이사 이재준 자본금 20,545백만 원 hy 외국인 기타 주요 사업 의료로봇사업, 임플란트 유통사업, 무역사업 임직원수 105명 (연구소 50명) 소재지 서울특별시 송파구 위례순환로 480, KR산업빌딩 3~4층 홈페이지 www.curexo.com Ô 2025 CUREXO Investor Relations
Slide 5: Strategic M&A Approval
No. 1 Korean Origin of Technology Strategic M&A Approval Entry into the Global Market Surgical Robotics Company • ISS(Interated Surgical • 현대중공업 의료로봇사업부를 • 보행재활로봇 'Morning Walk • 미국/일본/유럽등 • 국내 No.1 / 해외 Top Tier System) ROBODOC(IBM 투자 신주발행 양수(110억) S200' MFDS, FDA 및 CE 승인 글로벌시장 의료로봇기업 및 설립) 인수 및 개발
Slide 6: Revenue and operating profit trend
800 650 729 60.00% 700 50.00% 11.1 11.4 556 15 4.00% 40.00% 8.4 600 30.00% 10 2.00% 1.70% 1.60% 500 428 51.90% 20.00% 5 0.00% 400 12.15% 0 -2.00% FY21 FY22 FY23 FY24 FY25 1Q 300 8.90% 10.00% -5 -4.00% -4.20% 197 0.00% -6.00% -16.5 -10 200 -8.00% -23.70% -10.00% -15 -10.00% 100 -20.00% -20 -12.00% 0
Slide 7: Revenue by business segment
400 342 300 212 194 200 105 101 100 63 0 FY20 FY21 FY22 FY23 FY24 FY25 1Q 구분 FY20 FY21 FY22 FY23 FY24 FY25 1Q (단위 : 백만원, %) 금액 비중 금액 비중 금액 비중 금액 비중 금액 비중 금액 비중 의료로봇사업 6,336 16.1 10,465 24.5 21,224 32.7 34,196 46.9 19,406 34.9 10,066 51.1 임플란트사업 9,812 25.0 8,780 20.5 8,611 13.2 9,163 12.6 9,769 17.6
Slide 8: 2025 CUREXO Investor Relations
2025 CUREXO Investor Relations
Slide 9: 2025 CUREXO Investor Relations
2025 CUREXO Investor Relations
Slide 10: 2025 CUREXO Investor Relations
2025 CUREXO Investor Relations
Slide 11: CUREXO
sm CUREXO
Slide 12: 2025 CUREXO Investor Relations
2025 CUREXO Investor Relations
Slide 13: 2025 CUREXO Investor Relations
2025 CUREXO Investor Relations
Slide 14: 2025 CUREXO Investor Relations
2025 CUREXO Investor Relations
Slide 15: 2025 CUREXO Investor Relations
2025 CUREXO Investor Relations
Slide 16: CUREXO
sm CUREXO
Slide 17: 2025 CUREXO Investor Relations
2025 CUREXO Investor Relations
Slide 18: Income statement
구분 2022 2023 2024 2025 1Q 매출액 64,991 72,882 55,611 19,709 매출원가 50,601 53,584 40,903 13,377 판매관리비 13,279 18,163 20,451 5,266 영업이익 1,111 1,135 -5,744 843 당기순이익 -3,041 -4,856 -8,680 1,093 구분 23년 2Q 23년 3Q 23년 4Q 24년 1Q 24년 2Q 24년 3Q 24년 4Q 25년 1Q 매출액 19,780 16,440 17,138 13,942 13,513 13,240 14,917 19,
Slide 19: Growth and margins by segment
매출 42,795 64,991 72,882 55,611 19,709 성장률(yoy) 8.9% 51.9% 12.1% -23.7% 29.6% 매출원가 33,739 50,601 53,584 40,904 13,377 매출원가율 78.8% 77.9% 73.5% 73.6% 67.9% 영업이익 -1,817 1,111 1,135 -5,744 843 영업이익률 -4.2% 1.7% 1.6% -10.3% 4.3% 매출 10,465 21,224 34,196 19,406 10,066 매출 8,781 8,611 9,163 9,769 3,063 매출 23,5
Slide 20: Net financial assets, debt ratio, R&D ratio
순금융자산 부채비율 연구개발비율 60,387 42.9 17.0 50,176 47,420 42,268 12.7 13.4 10.4 9.3 20.5 10,367 9.0 6.9 10.0 FY21 FY22 FY23 FY24 FY25 1Q FY21 FY22 FY23 FY24 FY25 1Q FY21 FY22 FY23 FY24 FY25 1Q 2025 CUREXO Investor Relations
Slide 21: Detailed processes: CUVIS-Joint, CUVIS-Spine, Morning Walk
[별첨] 참고 : 세부 프로세스 CUVIS- Joint Process CUVIS - Spine Process Instrument Anchoring Pedicle Screw Target Selection Image Scan Pre-Surgical Planning &Tapping Insertion Morning- Walk 분석 Process 2025 CUREXO Investor Relations